Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Condition(s):MAC Lung Disease; Treatment Refractory MAC Lung DiseaseLast Updated:February 14, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):MAC Lung Disease; Treatment Refractory MAC Lung DiseaseLast Updated:February 14, 2024Active, not recruiting
Condition(s):Mycobacterium Avium Complex; Mycobacterium Avium-Intracellulare Infection; Gram-Positive Bacterial Infections; Mycobacterium InfectionsLast Updated:January 22, 2024Recruiting
Condition(s):Mycobacterium Avium Complex Lung DiseaseLast Updated:May 23, 2017Completed
Condition(s):Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Last Updated:February 28, 2024Recruiting
Condition(s):Mycobacterium Avium Complex Lung DiseaseLast Updated:May 23, 2017Completed
Condition(s):Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)Last Updated:January 5, 2024Recruiting
Condition(s):To Investigate the Inflammasome Response of Inflammatory and Resting Macrophage; To Compare the Difference of Inflammasome Response of Inflammatory Macrophage; To Study the Diagnostic Aid From Immunological Markers in Inflammasome ResponseLast Updated:June 30, 2014Unknown status
Condition(s):HIV Infections; Emphysema; Chronic Obstructive Pulmonary Disease; PneumocystisLast Updated:October 26, 2016Completed
Condition(s):Mycobacterium Avium ComplexLast Updated:May 23, 2017Completed
Condition(s):Mycobacterium Avium Complex; Non-tuberculous Mycobacterium Pulmonary DiseaseLast Updated:February 28, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.